OverviewChartNewsTraderScreen

BNP Paribas Knock-Out GILD/  DE000PR762M3  /

Frankfurt Zert./BNP
11/8/2024  9:50:22 PM Chg.-0.040 Bid9:59:19 PM Ask9:59:19 PM Underlying Strike price Expiration date Option type
4.640EUR -0.85% 4.620
Bid Size: 5,000		 4.630
Ask Size: 5,000		 Gilead Sciences Inc 47.0451 USD 12/31/2078 Call
GlobeNewswire 8/27 Alex Bastian joins Memo Therapeutics AG as VP Commercial Strategy
GlobeNewswire 8/27 Alex Bastian joins Memo Therapeutics AG as VP Commercial Strategy
GlobeNewswire 8/8 HOOKIPA Pharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire 8/8 Assembly Biosciences Reports Second Quarter 2024 Financial Results and Recent Updates
GlobeNewswire 8/8 Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2024 Financial Results
GlobeNewswire 8/6 MacroGenics Provides Update on Corporate Progress, Second Quarter 2024 Financial Results
GlobeNewswire 8/5 89bio Reports Second Quarter 2024 Financial Results and Corporate Updates
GlobeNewswire 8/5 89bio Appoints Charles McWherter, Ph.D., to its Board of Directors
GlobeNewswire 8/1 Merus Announces Financial Results for the Second Quarter 2024 and Provides Business Update
GlobeNewswire 7/23 ACTG Presents Data Analysis at AIDS 2024 Showing Association between Elevated Risk of Cardiovascular...
GlobeNewswire 7/15 Assembly Biosciences Presents New Preclinical Data Highlighting Investigational Helicase-Primase Inh...
GlobeNewswire 7/8 Memo Therapeutics AG appoints Paul Carter as Chairperson
GlobeNewswire 7/8 Memo Therapeutics AG appoints Paul Carter as Chairperson
GlobeNewswire 7/4 Burns McClellan Mourns the Passing of Founder and CEO, Lisa Burns
GlobeNewswire 7/1 HOOKIPA Pharma Announces First Person Dosed in Phase 1b Clinical Trial of HB-500 for the Treatment o...
GlobeNewswire 7/1 Vera Therapeutics Announces Appointment of Industry Veteran David L. Johnson as Chief Operating Offi...
GlobeNewswire 6/28 Ensho Therapeutics Launches with Phase 2-Ready Oral α4β7 Inhibitor for Inflammatory Bowel Disease
GlobeNewswire 6/26 Neurona Therapeutics Appoints Dr. Nadia Agopyan as Senior Vice President of Regulatory Affairs
GlobeNewswire 6/26 Oruka Therapeutics Announces Key Additions to Leadership Team and Board of Directors
TeleTrader 6/20 US opens mostly higher after labor, housing data
GlobeNewswire 6/18 Assembly Biosciences Doses First Participant in Phase 1b Clinical Trial Evaluating Next-Generation C...
GlobeNewswire 6/17 Assembly Biosciences Announces $12.6 Million in Equity Financings
GlobeNewswire 6/10 Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus He...
GlobeNewswire 5/22 Assembly Biosciences to Present Data at Upcoming International Herpesvirus Workshop and EASL Congres...
GlobeNewswire 5/14 Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results